Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Compounding Policies

Posted by Matt Breese on Jan 18, 2018

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is pharmacy compounding regulations.

The U.S. Food and Drug Administration recently issued it's 2018 Compounding Policy Priorities Plan. 

Read More

Topics: Industry Trends

Perspectives on the Migraine Pipeline

Posted by Matt Breese on Jan 16, 2018

Approximately 39 million Americans are affected by migraines, according to the Modern Medicine Network.
 
Several drug developers are working to expand treatment options for migraines.  In 2018, we'll see more activity in the specialty migraine pipeline. 
 
Read More

Topics: Specialty

Trends That Matter for HGH Treatments

Posted by Matt Breese on Jan 11, 2018

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is human growth hormone (HGH) treatments. 

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Read More

Topics: Market Access, Data & Analytics

Perspectives on Pharma Globalization

Posted by Matt Breese on Jan 9, 2018

The global pharmaceutical market is a significant contributor to the world economy. The pharma markets in the U.S., Japan, and China have the highest revenues
 
However, according to BioPharmaDive, "Increasing pricing pressures and a rapidly growing (and aging) population — means big pharma companies are looking toward untapped markets."  In 2018, we will likely see  smaller pharma companies pushing to expand their global reach.
 
Read More

Topics: Market Access

MMIT Reality Check on Growth Hormones (Jan 2018)

Posted by Matt Breese on Jan 8, 2018

According to our recent payer coverage analysis for HGH treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Market Access, Data & Analytics, Branding & Marketing

Trends That Matter for Pain Relief

Posted by Matt Breese on Jan 4, 2018

In our weekly Trends that Matter series, we provide infographics, articles and recent news from influencers to highlight general trends affecting the pharmaceutical and healthcare industries. This week's featured topic is pain relief treatments. 

Neighborhood Health Plan (NHP) will soon begin broadly offering certain prevention, rehabilitation and drug-free pain relief treatments and prescriptions cost-free to members.

Read More

Topics: Industry Trends, Payer

Perspectives on Drug Naming Policies

Posted by Matt Breese on Jan 2, 2018

When it comes time to name your pharmaceutical brand asset, there are important regulations to keep in mind. Gaining approval on a product name can impact your ability to stay on track for a product launch timeline. 
 
In 2017, the FDA published an industry guide on the Nonproprietary Naming of Biological Products. This guide is an excellent resource for pharma leaders.
 
Read More

Topics: Branding & Marketing

MMIT Reality Check on Diabetes (Dec 2017)

Posted by Matt Breese on Dec 31, 2017

According to our recent payer coverage analysis for type 2 diabetes treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Which Disease Areas Are On Your Mind Going Into 2018?

Posted by Matt Breese on Dec 31, 2017

We reviewed activity across major disease areas featured in 2017 MMIT Reality Checks and gathered poll data from pharma brand teams to understand where the biggest buzz is within market access. The following disease areas (in order) is where we received the most interest - some of these surprised us...

Read More

Topics: Specialty, Industry Trends, Market Access, Branding & Marketing

Trends That Matter for Hypertension

Posted by Matt Breese on Dec 28, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from influencers to highlight general trends affecting the pharmaceutical and healthcare industries. This week's featured topic is hypertension. 

A new clinical practice guideline’s lower threshold for hypertension increases the prevalence of the condition to include nearly half of adults in the U.S. But this doesn’t necessarily mean patients below the old standard will require antihypertensive drugs.

Read More

Topics: Industry Trends